歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

午间休市 01-19 11:59:53

12.900

-0.480

-3.59%

最高13.140	最低12.730	成交量74.10万
今开13.140	昨收13.380	日振幅3.06%
总市值127.97亿	流通市值127.97亿	总股本9.92亿
成交额951.54万	换手率0.07%	流通股本9.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":12.9,"timestamp":1768795193676,"preClose":13.38,"halted":0,"volume":741000,"delay":0,"changeRate":-0.035874439461883435,"floatShares":992000000,"shares":992000000,"eps":-0.33662595411349233,"marketStatus":"午间休市","change":-0.48,"latestTime":"01-19 11:59:53","open":13.14,"high":13.14,"low":12.73,"amount":9515380,"amplitude":0.030643,"askPrice":12.92,"askSize":7000,"bidPrice":12.85,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.2972301702618634,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768798800000},"marketStatusCode":3,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":13.38,"openAndCloseTimeList":[[1768786200000,1768795200000],[1768798800000,1768809600000]],"volumeRatio":0.578167,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2603603390","title":"每日卖空追踪 | 歌礼制药-B 01月15日卖空量成交17.7万股，卖空比例为4.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603390?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465823,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间01月15日，涨2.44%，卖空量成交17.7万股，较上一交易日减少59.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164024a71dc75e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164024a71dc75e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1515","BK1191","01672","01477"],"gpt_icon":0},{"id":"2603603355","title":"歌礼制药-B01月15日主力净流入622.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603355?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:15","pubTimestamp":1768464928,"startTime":"0","endTime":"0","summary":"01月15日, 歌礼制药-B股价涨2.44%，报收13.87元，成交金额5567.2万元，换手率0.41%，振幅5.02%，量比1.65。歌礼制药-B今日主力资金净流入622.2万元，上一交易日主力净流出259.0万元。该股近5个交易日上涨10.86%，主力资金累计净流入355.4万元；近20日主力资金累计净流出603.4万元，其中净流出天数为7日。该股主力净额占比0.05%，港股市场排名144/2710。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115161759a4c6b8f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115161759a4c6b8f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","BK1191","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2603767664","title":"港股异动 | 歌礼制药-B(01672)午后拉升逾6% ASC30数据亮眼 公司上调回购资金上限至5亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603767664","media":"智通财经","labels":["dataReport","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603767664?lang=zh_cn&edition=full","pubTime":"2026-01-14 14:33","pubTimestamp":1768372394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B(01672)午后拉升逾6%，截至发稿，涨6.14%，报13.66港元，成交额3585.02万港元。消息面上，歌礼制药此前公布其口服GLP-1药物ASC30用于治疗肥胖症的美国IIa期研究正向数据。花旗发布研报称，这些数据进一步展现了ASC30同类最佳的潜力，并增强了未来合作信心。预期股价将有正面反应；重申“买入/高风险”评级，目标价32港元。值得注意的是，歌礼制药此前发布公告称，公司董事会认为本公司现时股价被低估，并于12月15日决议将股份购回资金由最多3亿港元增至最多5亿港元，此决策基于多项核心管线重大进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1161","01477","BK1574","BK1515","01672"],"gpt_icon":0},{"id":"1137978914","title":"港股创新药概念股盘初普涨！乐普生物-B涨超8%，药明康德涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137978914","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137978914?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:45","pubTimestamp":1768268737,"startTime":"0","endTime":"0","summary":"1月13日，港股创新药概念股盘初普涨，$乐普生物-B(02157)$涨超8%，$药明康德(02359)$涨超7%，$三生制药(01530)$、$晶泰控股(02228)$涨超6%，$歌礼制药-B(01672)$涨超4%，$复星医药(02196)$、$云顶新耀(01952)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","01530","BK1576","LU0708995583.HKD","HK0000165453.HKD","BK1583","LU2242644610.SGD","01672","LU0052750758.USD","01952","01477","BK1515","LU1046422090.SGD","LU2045819591.USD","BK1161","BK1617","LU0320764599.SGD","BK1141","LU2125910500.SGD","BK1593","BK1574","02196","02157","02228","02359"],"gpt_icon":0},{"id":"2601526363","title":"每日卖空追踪 | 歌礼制药-B 01月08日卖空量成交27.7万股，卖空比例为9.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601526363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601526363?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861025,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间01月08日，涨1.05%，卖空量成交27.7万股，较上一交易日减少25.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164538a7023b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164538a7023b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1161","BK1191","01477","BK1515"],"gpt_icon":0},{"id":"2601395905","title":"歌礼制药-B01月08日主力净流入66.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601395905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601395905?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860140,"startTime":"0","endTime":"0","summary":"01月08日, 歌礼制药-B股价涨1.05%，报收12.52元，成交金额3573.9万元，换手率0.29%，振幅6.05%，量比1.06。歌礼制药-B今日主力资金净流入66.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨10.62%，主力资金累计净流入545.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4336.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162227a7022353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162227a7022353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","01477","01672","BK1161","BK1191"],"gpt_icon":0},{"id":"2601849974","title":"每日卖空追踪 | 歌礼制药-B 01月06日卖空量成交23.7万股，卖空比例为7.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601849974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601849974?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:30","pubTimestamp":1767688223,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间01月06日，跌2.68%，卖空量成交23.7万股，较上一交易日减少29.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163349a6f9834c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106163349a6f9834c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01477","BK1574","01672","BK1515","BK1191"],"gpt_icon":0},{"id":"2601849942","title":"Tides 速递 | 歌礼制药口服 GLP-1 药物 II期研究IND获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2601849942","media":"多肽圈","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601849942?lang=zh_cn&edition=full","pubTime":"2026-01-06 09:23","pubTimestamp":1767662637,"startTime":"0","endTime":"0","summary":"｜中肽生化内容团队编辑2026年1月5日，歌礼制药有限公司今日宣布，近期已获得美国食品药品监督管理局对其口服小分子GLP-1，ASC30，在糖尿病受试者中的II期研究的新药临床试验的批准。该II期研究将在美国多个中心入组约100例2型糖尿病的受试者。歌礼已于近期完成其评估口服小分子GLP-1受体激动剂ASC30治疗肥胖症的13周II期研究。在ASC30用于治疗肥胖或超重的II期研究中，因不良事件导致的总体停药率为4.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106094459a6f80168&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106094459a6f80168&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01477","BK1515","BK1191","01672"],"gpt_icon":0},{"id":"2601838590","title":"每日卖空追踪 | 歌礼制药-B 01月05日卖空量成交16.3万股，卖空比例为5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601838590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601838590?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601822,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间01月05日，涨7.03%，卖空量成交16.3万股，较上一交易日减少27.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163505a6f52401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163505a6f52401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01672","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"1100237131","title":"港股异动 | 创新药概念股走高，歌礼制药涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100237131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100237131?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:19","pubTimestamp":1767579594,"startTime":"0","endTime":"0","summary":"1月5日，港股创新药概念股盘中走高，$歌礼制药-B(01672)$涨近10%，$信达生物(01801)$、$云顶新耀(01952)$、$科伦博泰生物-B(06990)$涨超5%，$百济神州(06160)$、$再鼎医药(09688)$、$三生制药(01530)$涨超4%，$石药集团(01093)$、$药明康德(02359)$涨超3%。歌礼制药-B","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f1a65319f224684be7c4d1ad3324a2f2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","01672","02359","09688"],"gpt_icon":0},{"id":"2601383048","title":"歌礼制药发布口服小分子GLP-1研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2601383048","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601383048?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:05","pubTimestamp":1767575103,"startTime":"0","endTime":"0","summary":"歌礼制药宣布其口服小分子GLP-1药物在临床试验中取得积极进展，显示出良好的安全性和药代动力学特征。该药物用于治疗2型糖尿病和肥胖症，具有每日一次给药的优势，目前处于II期临床阶段。研究覆盖多个国际临床中心，初步数据支持进一步开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105091309a6f3935d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105091309a6f3935d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","01672","BK1191","01477"],"gpt_icon":0},{"id":"2601785620","title":"歌礼制药-B(01672)宣布ASC30在糖尿病受试者中的 13周II期研究IND获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2601785620","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601785620?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:13","pubTimestamp":1767572009,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 公布，近期已获得美国食品药品监督管理局 对其口服小分子GLP-1，ASC30，在糖尿病受试者中的II期研究的新药临床试验的批准。该II期研究是一项为期13周、随机、双盲、安慰剂对照及多中心的研究，旨在评估ASC30在2型糖尿病受试者中的疗效、安全性和耐受性。歌礼已于近期完成其评估口服小分子GLP-1受体激动剂ASC30治疗肥胖症的13周II期研究。在ASC30用于治疗肥胖或超重的II期研究中，因不良事件导致的总体停药率为4.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f1a65319f224684be7c4d1ad3324a2f2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1191","IND","BK1515","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"2600450700","title":"智通港股回购统计|1月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2600450700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600450700?lang=zh_cn&edition=full","pubTime":"2026-01-01 09:10","pubTimestamp":1767229801,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量106.10 万，回购金额6.35 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02598","02652","01024","02869","02509","02299","02391","06608","09959","06098","02219","09886","09922","06100","02416","02517","01810","00700","01588","01897","02621","02038","06831","00314","09966","01868","06078","02121","01651","02018","00909","02866","02886","02419","09878","02586","02142","01516","01458","03650","03798","02678","01995","01600","00345","09896","01672","09857","01274","06609"],"gpt_icon":1},{"id":"2600945707","title":"2026年一个注定燃爆的BD方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2600945707","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600945707?lang=zh_cn&edition=full","pubTime":"2026-01-01 07:32","pubTimestamp":1767223923,"startTime":"0","endTime":"0","summary":"司美格鲁肽原研由诺和诺德开发，但随着其核心专利将于2026年3月到期，中国市场正在上演激烈的司美格鲁肽生物类似药争夺战。截至目前，国内已有10款国产司美格鲁肽申报上市，并有10款已进入临床III期阶段。展望减重领域的下一个BD热点，三靶点GLP-1或是其中之一。全球口服小分子GLP-1R激动剂研发管线（部分）图源：国金证券研报展望2026年，减脂不减肌药物、小核酸减重药物有望成为下一个BD“金矿”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101075803a6e722f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101075803a6e722f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","LU1023057109.AUD","BK1191","LU0359201885.HKD","LU2543165471.USD","01276","01801","01672","LU0359202008.SGD"],"gpt_icon":0},{"id":"2595813687","title":"歌礼制药-B(01672)12月29日斥资248.29万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595813687","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595813687?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:22","pubTimestamp":1767003744,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月29日，该公司斥资248.29万港元回购20万股股份，每股回购价格为12.17-12.66港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01477","BK1191","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"2595766925","title":"每日卖空追踪 | 歌礼制药-B 12月29日卖空量成交14万股，卖空比例为6.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595766925","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595766925?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997022,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月29日，跌3.57%，卖空量成交14万股，较上一交易日减少16.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163253a6dc4814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163253a6dc4814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1515","BK1191","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2595203585","title":"东方证券：首予歌礼制药-B(01672)“买入”评级 目标价18.38港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595203585","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595203585?lang=zh_cn&edition=full","pubTime":"2025-12-29 10:27","pubTimestamp":1766975272,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，东方证券发布研报称，预测歌礼制药-B2025-2027年每股收益分别为-0.32/-0.35/-0.38元，对公司自由现金流进行绝对估值，预测公司合理市值为183.66亿港元，对应目标价为18.38港元，首次给予“买入”评级。当前减重药物主要为GLP-1药物，临床中使用率低、依从性差、停药后体重反弹明显和瘦体重流失问题较为突出。该行认为，ASC30减重数据优越，安全性良好，且分子专利已获美国授权，BD潜力较大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01477","01672","03958","600958"],"gpt_icon":0},{"id":"2593403575","title":"每日卖空追踪 | 歌礼制药-B 12月24日卖空量成交16.7万股，卖空比例为16.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593403575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593403575?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565021,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月24日，涨1.69%，卖空量成交16.7万股，较上一交易日减少69.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163320a4727ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163320a4727ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","01477","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2593944268","title":"智通港股回购统计|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593944268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593944268?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:10","pubTimestamp":1766538601,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量105.10 万，回购金额6.36 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01600","02367","00175","01588","02121","02598","06826","09878","02038","01583","01919","01995","02869","01907","02219","02251","02299","00697","00799","01672","02171","00947","00345","02392","03888","06100","01810","02416","02018","00700","01458","02678","01024","09959","09923","09857","00732","00909","09896","02167","01317","00434","01651","09886","06868","02419","02886","01773","06078","00314"],"gpt_icon":1},{"id":"1130488131","title":"港股创新药概念股盘中拉升！石药集团涨超5%，荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130488131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130488131?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:04","pubTimestamp":1766455472,"startTime":"0","endTime":"0","summary":"12月23日，港股创新药概念股盘中拉升，$石药集团(01093)$涨超5%，$恒瑞医药(01276)$、$三生制药(01530)$涨近3%，$先声药业(02096)$、$歌礼制药-B(01672)$、$康诺亚-B(02162)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"26e483f2c2080ad5ab71efdf30a08f1a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","01093","01530","02162","06978","01477","01276","01672"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":0.0627},{"period":"1month","weight":0.019},{"period":"3month","weight":0.4719},{"period":"6month","weight":0.1515},{"period":"1year","weight":2.686},{"period":"ytd","weight":0.1747}],"compareEarnings":[{"period":"1week","weight":0.0234},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0633},{"period":"6month","weight":0.0813},{"period":"1year","weight":0.3751},{"period":"ytd","weight":0.0474}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.142273},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.428571,"avgChangeRate":0.007612},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.024499},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032162},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.037953},{"month":9,"riseRate":0.125,"avgChangeRate":-0.072967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023171},{"month":11,"riseRate":0.875,"avgChangeRate":0.185422},{"month":12,"riseRate":0.5,"avgChangeRate":0.087327}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}